In an interview last year with online US health publication Stat, the German financier and lifelong teetotaller Christian Angermayer described the single most meaningful experience in his life. Five years previously, at the age of 35, he travelled with friends to a country where psychedelic drugs are legal and had his first trip. It was, for him, utterly transformative. “Nothing has ever come close to it,” he said.  As an entrepreneur, Angermayer soon began investigating the business potential of developing psychoactive drugs into approved medications. Psilocybin, found in magic mushrooms, is currently being researched for its potential benefits to patients…

Want to read the full story?

Unlock this article – and everything else on The Currency – with an annual membership and receive a free Samsonite Upscape suitcase, retailing at €235, delivered to your door.

Subscribe

Cancel at any time.

Are you already a member? .